Class of 2030: India’s on the cusp of an electric future. But who’s going to build it?

UPDATE: On 7 March, the government officially announced a 15% import subsidy on lithium. The Ken had earlier reported a 5% subsidy rate, as told to us by a senior official in the know of FAME-II policy discussions. 2019 will be the year of the perfect electric storm. This is the year that India might … Read more Class of 2030: India’s on the cusp of an electric future. But who’s going to build it?

Privacy terror to adtech: SilverPush’s rise from the ashes

Could I have seen the adverts? “You could have, you could have,” says Hitesh Chawla. What are those brands, if you could name them? In his dimly lit glass cabin on the third floor of a mall in Gurugram, Chawla, co-founder of SilverPush, a company which sells technology solutions to target consumers with ads across … Read more Privacy terror to adtech: SilverPush’s rise from the ashes

Missed deadlines and half-measures: India’s telecom equipment has a security problem

Despite being the second-largest smartphone market in the world—not to mention the fastest growing—India has very few checks and balances in place to control telecom equipment quality. This has resulted in everything from mobile phone batteries heating up or outright exploding. Radiation emissions being above prescribed limits. And the very real threat of data theft … Read more Missed deadlines and half-measures: India’s telecom equipment has a security problem

Moving the needle: MIA for 20 years, Parkinson’s drug Apomorphine still evades Indians

P hasn’t been able to walk properly and has suffered from tremors for over 12 years. He is shown getting a shot, and seconds later, he’s seen doing push-ups. Mumbai-based Nanavati Hospital’s video on its antidote to Parkinson’s Disease, uploaded earlier this month, seems too good to be true. In fact, neurologists all over the … Read more Moving the needle: MIA for 20 years, Parkinson’s drug Apomorphine still evades Indians